Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control

OBJECTIVE: Optimal glycemic control slows diabetic retinopathy (DR) development and progression and is the standard of care for type 1 diabetes. However, these glycemic goals are difficult to achieve and sustain in clinical practice. The Renin Angiotensin System Study (RASS) showed that renin-angiot...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Harindhanavudhi, Tasma, Mauer, Michael, Klein, Ronald, Zinman, Bernard, Sinaiko, Alan, Caramori, M. Luiza
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Diabetes Association 2011
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3142059/
https://ncbi.nlm.nih.gov/pubmed/21715517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-0476
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg